UroGen Pharma (URGN) option IV into data
Tweet
Share
E-mailGet Alerts URGN Hot Sheet
Join SI Premium – FREE
UroGen Pharma (NASDAQ: URGN) 30-day option implied volatility is at 227; compared to its 52-week range of 59 to 228 into reports 82.3% 12-month duration of response data from Phase 3 trial.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft (MSFT) call put ratio 2.6 calls to 1 put into quarter results
- Active options: NVDA TSLA AAPL MU INTC MSFT AMD AMZN GOOGL SPCX
- Agilysys Inc (AGYS) PT Raised to $118 at Oppenheimer
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
